Abstract
Objective: The magnitude of ST elevation is a key piece of information in the decision to thrombolyse in acute myocardial infarction. The ability of clinicians to reliably identify ST elevation has not been previously assessed. This study sought to determine the variability in assessment of ST elevation in a group of doctors who commonly prescribe thrombolysis.
Methods: The study was conducted in three large teaching hospitals in Manchester, England. A convenience sample of 63 SHOs and SpRs from emergency and general medicine were recruited. Each was shown three sample ECG complexes. They were asked to identify and quantify the degree of ST elevation. They then indicated the points on the ECG from which they measured ST elevation.
Results: ST elevation was not identified in 12% of cases. Doctors used a wide variety of points on the ST segment to assess elevation, this resulted in a wide variation in the observed magnitude of ST elevation.
Conclusion: No guidance exists on where exactly ST elevation should be measured. This study shows a wide variation in practice. Protocol led thrombolysis decision pathways may be compromised by these findings.
Full Text
The Full Text of this article is available as a PDF (80.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med. 1993 Sep 2;329(10):673–682. doi: 10.1056/NEJM199309023291001. [DOI] [PubMed] [Google Scholar]
- Bates E. R., Califf R. M., Stack R. S., Aronson L., George B. S., Candela R. J., Kereiakes D. J., Abbottsmith C. W., Anderson L., Pitt B. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortality. J Am Coll Cardiol. 1989 Jan;13(1):12–18. doi: 10.1016/0735-1097(89)90542-1. [DOI] [PubMed] [Google Scholar]
- Chesebro J. H., Knatterud G., Roberts R., Borer J., Cohen L. S., Dalen J., Dodge H. T., Francis C. K., Hillis D., Ludbrook P. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987 Jul;76(1):142–154. doi: 10.1161/01.cir.76.1.142. [DOI] [PubMed] [Google Scholar]
- Gjørup T., Kelbaek H., Nielsen D., Kreiner S., Godtfredsen J. Interpretation of the electrocardiogram in suspected myocardial infarction: a randomized controlled study of the effect of a training programme to reduce interobserver variation. J Intern Med. 1992 Apr;231(4):407–412. doi: 10.1111/j.1365-2796.1992.tb00952.x. [DOI] [PubMed] [Google Scholar]
- Jayes R. L., Jr, Larsen G. C., Beshansky J. R., D'Agostino R. B., Selker H. P. Physician electrocardiogram reading in the emergency department--accuracy and effect on triage decisions: findings from a multicenter study. J Gen Intern Med. 1992 Jul-Aug;7(4):387–392. doi: 10.1007/BF02599153. [DOI] [PubMed] [Google Scholar]
- Koren G., Weiss A. T., Hasin Y., Appelbaum D., Welber S., Rozenman Y., Lotan C., Mosseri M., Sapoznikov D., Luria M. H. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med. 1985 Nov 28;313(22):1384–1389. doi: 10.1056/NEJM198511283132204. [DOI] [PubMed] [Google Scholar]
- Rawles J. Magnitude of benefit from earlier thrombolytic treatment in acute myocardial infarction: new evidence from Grampian region early anistreplase trial (GREAT) BMJ. 1996 Jan 27;312(7025):212–215. doi: 10.1136/bmj.312.7025.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tandberg D., Kastendieck K. D., Meskin S. Observer variation in measured ST-segment elevation. Ann Emerg Med. 1999 Oct;34(4 Pt 1):448–452. doi: 10.1016/s0196-0644(99)80045-6. [DOI] [PubMed] [Google Scholar]
- Verstraete M., Bernard R., Bory M., Brower R. W., Collen D., de Bono D. P., Erbel R., Huhmann W., Lennane R. J., Lubsen J. Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator. Lancet. 1985 Apr 13;1(8433):842–847. doi: 10.1016/s0140-6736(85)92208-1. [DOI] [PubMed] [Google Scholar]
- Wilcox R. G., von der Lippe G., Olsson C. G., Jensen G., Skene A. M., Hampton J. R. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet. 1988 Sep 3;2(8610):525–530. doi: 10.1016/s0140-6736(88)92656-6. [DOI] [PubMed] [Google Scholar]